Back
Business
-
Briefly
CHENNAI: Wockhardt has launched Midazolam injection in the U.S. The company has received approval from the U.S. Food and Drug Administration (US FDA) for marketing the preservative-free version injections containing one mg/ml and 5mg/ml Midazolam, which is used for treating acute insomnia and anxiety, says a company release. — Corporate Reporter © Copyright 2000 - 2009 The Hindu |